Profiel
Michael A.
Yamin served as the Director & Vice President at Angion Biomedica Corp.
from 2013 to 2020.
Prior to that, he obtained a doctorate degree from The Rockefeller University.
Eerdere bekende functies van Michael A. Yamin
| Bedrijven | Functie | Einde |
|---|---|---|
| ANGN BIOM | Directeur/Bestuurslid | 04-06-2020 |
Opleiding van Michael A. Yamin
| The Rockefeller University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Angion Biomedica Corp.
 Angion Biomedica Corp. Pharmaceuticals: MajorHealth Technology Angion Biomedica Corp. operates as a biopharmaceutical company. The firm focuses on the discovery and development of novel therapeutic agents to address acute organ injuries and fibrotic diseases. Its product pipeline includes ANG-3777, ANG-3070, ROCK2 Inhibitor and CYP11B2 Inhibitors. The company was founded by Itzhak D. Goldberg on April 6, 1998 and is headquartered in Newton, MA. | Health Technology |
